PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma
出版年份 2019 全文链接
标题
PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma
作者
关键词
-
出版物
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-05-17
DOI
10.1186/s13046-019-1194-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic target
- (2018) Gustav van Niekerk et al. CELLULAR ONCOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting mitochondria in cancer: current concepts and immunotherapy approaches
- (2018) Sergey Pustylnikov et al. Translational Research
- Tannic acid directly targets pyruvate kinase isoenzyme M2 to attenuate colon cancer cell proliferation
- (2018) Peng Yang et al. Food & Function
- Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma
- (2018) Giuseppa Augello et al. INTERNATIONAL JOURNAL OF CANCER
- Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma
- (2018) Ruiqi Liu et al. CANCER LETTERS
- Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
- (2017) Daniela Sia et al. GASTROENTEROLOGY
- By inhibiting PFKFB3, aspirin overcomes sorafenib resistance in hepatocellular carcinoma
- (2017) Sainan Li et al. INTERNATIONAL JOURNAL OF CANCER
- HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma
- (2017) Qiuran Xu et al. Molecular Cancer
- Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression
- (2017) Libin Wei et al. Cell Death & Disease
- Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
- (2017) Nader N. Massarweh et al. Cancer Control
- Plasma HSP90α and liver cancer: a potential biomarker?
- (2017) Carole Sourbier EBioMedicine
- Plasma Heat Shock Protein 90alpha as a Biomarker for the Diagnosis of Liver Cancer: An Official, Large-scale, and Multicenter Clinical Trial
- (2017) Yan Fu et al. EBioMedicine
- Procyanidins from Nelumbo nucifera Gaertn. Seedpod induce autophagy mediated by reactive oxygen species generation in human hepatoma G2 cells
- (2016) Yuqing Duan et al. BIOMEDICINE & PHARMACOTHERAPY
- Nuclear PKM2 expression, an independent risk factor for ER after curative resection of hepatocellular carcinoma
- (2016) Fangtian Fan et al. BIOMEDICINE & PHARMACOTHERAPY
- PKM2, cancer metabolism, and the road ahead
- (2016) Talya L Dayton et al. EMBO REPORTS
- HSP90 inhibits apoptosis and promotes growth by regulating HIF-1α abundance in hepatocellular carcinoma
- (2016) XIN LIU et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism
- (2016) Chenwei Pan et al. PLoS One
- Hypoxia-inducible factor-1alpha in hepatic fibrosis: A promising therapeutic target
- (2015) Lei Zhan et al. BIOCHIMIE
- Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1α and Bcl-xL in culture
- (2015) Tianfu Dong et al. BIOMEDICINE & PHARMACOTHERAPY
- Pyruvate Kinase M2 Regulates Hif-1α Activity and IL-1β Induction and Is a Critical Determinant of the Warburg Effect in LPS-Activated Macrophages
- (2015) Eva M. Palsson-McDermott et al. Cell Metabolism
- Procyanidin B2 3,3″-di-O-gallate Inhibits Endothelial Cells Growth and Motility by Targeting VEGFR2 and Integrin Signaling Pathways
- (2015) Rahul Kumar et al. CURRENT CANCER DRUG TARGETS
- Protective Effect of Procyanidin B2 against CCl4-Induced Acute Liver Injury in Mice
- (2015) Bing-Ya Yang et al. MOLECULES
- The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing
- (2015) Valentina Tesori et al. Scientific Reports
- Effect of Grape Procyanidins on Tumor Angiogenesis in Liver Cancer Xenograft Models
- (2014) Li-Li Feng et al. Asian Pacific Journal of Cancer Prevention
- Procyanidin B2inhibits inflammasome-mediated IL-1β production in lipopolysaccharide-stimulated macrophages
- (2014) Neus Martinez-Micaelo et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Liver cancer
- (2014) Lauren Gravitz NATURE
- Switching of Pyruvate Kinase Isoform L to M2 Promotes Metabolic Reprogramming in Hepatocarcinogenesis
- (2014) Carmen Chak-Lui Wong et al. PLoS One
- Mitochondria-Targeted Drugs Synergize with 2-Deoxyglucose to Trigger Breast Cancer Cell Death
- (2012) G. Cheng et al. CANCER RESEARCH
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
- (2012) Dimitrios Anastasiou et al. Nature Chemical Biology
- Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
- (2011) Sophia Y. Lunt et al. Annual Review of Cell and Developmental Biology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells
- (2011) Luigi Fiume et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Role of hypoxia-inducible transcription factor 1α for progression and chemosensitivity of murine hepatocellular carcinoma
- (2010) Katjana Daskalow et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Multi-targeted prevention and therapy of cancer by proanthocyanidins
- (2008) Vijayalakshmi Nandakumar et al. CANCER LETTERS
- Molecular mechanisms of hepatocellular carcinoma
- (2008) Rajagopal N. Aravalli et al. HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started